[
  {
    "id": "hpv-associated_30199_1750166911.txt-1",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#definitiongeneral236392",
    "clean_content": "Definition / general\n\n* An increasing subset of oropharyngeal carcinomas caused by high risk human papillomaviruses (HPV) ([El-Naggar: WHO Classification of Head and Neck Tumours, 4th Edition, 2017](https://www.amazon.com/exec/obidos/ASIN/9283224388/pathologyoutl-20))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-2",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#essentialfeatures236393",
    "clean_content": "Essential features\n\n* Oropharyngeal squamous cell carcinoma caused by high risk HPV* Mostly present as a cystic or solid neck mass, enlarged cervical lymph node, or rarely enlarged tonsil* Variable squamous differentiation characterized by orangeophilic keratinized squamous cells in Papanicolaou stain* p16 immunostain, a surrogate marker for high risk HPV, is considered positive when expressed in ≥ 70% of tumor cells with both nuclear and cytoplasmic staining; occasionally p16 is focal / patchy positive or negative* High risk HPV can be detected by different methods such as RNA in situ hybridization* High risk HPV testing can be performed on both primary or metastatic tumor* No tumor grading* Overall favorable prognosis despite early local lymph node metastasis ([Cancer Epidemiol Biomarkers Prev 2019;28:1660](31358520))* Rare cases associated with distant metastasis and poor prognosis* HPV+ squamous cell carcinoma is associated with better prognosis than HPV- squamous cell carcinoma"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-3",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#terminology236394",
    "clean_content": "Terminology\n\n* Also known as HPV+ squamous cell carcinoma of oropharyngeal origin ([El-Naggar: WHO Classification of Head and Neck Tumours, 4th Edition, 2017](https://www.amazon.com/exec/obidos/ASIN/9283224388/pathologyoutl-20))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-4",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#epidemiology236395",
    "clean_content": "Epidemiology\n\n* Affects both males and females, more common in white males, mostly younger than 65* Incidence is growing rapidly ([J Clin Oncol 2011;29:4294](21969503))* U.S. incidence of oropharyngeal HPV+ squamous cell carcinoma is higher than the incidence of HPV- cases, 4.62 versus 1.82 per 100,000 ([Cancer Epidemiol Biomarkers Prev 2019;28:1660](31358520))* Patients are younger, predominantly Caucasians and higher socioeconomic status compered to HPV- squamous cell carcinoma"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-5",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#sites236396",
    "clean_content": "Sites\n\n* Most common in oropharynx (tonsils, base of tongue and adenoids) and posterior pharyngeal wall* Arise from the tonsillar crypts"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-6",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#pathophysiology236397",
    "clean_content": "Pathophysiology\n\n* Etiologic agent is high risk HPV* Arises from the tonsillar crypts* Initial step is infection of the epithelial basal layer by HPV through microabrasions or trauma* HPV double stranded DNA genome encodes oncoproteins such as Early genes *E1, E2, E6* and *E7* after integration into the host cell nucleus ([J Dent Res 2015;94:1532](26353884))* *E1 and E2* genes activate viral replication* E6 binds to p53 and inactivates tumor suppressor protein p53 and E7 binds to pRB and inactivates tumor suppressor protein pRB* E6 and E7 expression promotes cellular proliferation and increases chance of malignancy ([J Am Soc Cytopathol 2016;5:203](31042510))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-7",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#etiology236398",
    "clean_content": "Etiology\n\n* Caused by high risk HPV, mostly commonly associated with HPV16 and HPV18 strains* Also includes high risk HPV strains 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 82, as well as others ([Cancer Epidemiol Biomarkers Prev 1996;5:567](8827362))* Oral sexual contact is a major risk factor, but not alcohol or tobacco (smoking or chewing)"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-8",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#clinicalfeatures236399",
    "clean_content": "Clinical features\n\n* Initial presentation in most cases is a neck mass or cervical lymphadenopathy* Occasionally presents with a unilateral enlarged tonsil* May have distant metastases to the lungs, mediastinal lymph nodes, brain, liver, bone, skin, duodenum ([J Am Soc Cytopathol 2016;5:203](31042510))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-9",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#diagnosis236400",
    "clean_content": "Diagnosis\n\n* Tissue findings in which morphology, along with nuclear and cytoplasmic expression of [p16](https://www.pathologyoutlines.com/topic/stainsp16.html) in ≥ 70% of tumor cells or detection of high risk HPV in tumor cells, is required for the diagnosis"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-10",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#radiologydescription236401",
    "clean_content": "Radiology description\n\n* Imaging findings, including ultrasound, such as enlargement, loss of the central fatty hilum, irregular cortical thickening, increased vascularity and loss of elongated shape are suspicious characteristics for metastatic HPV related squamous cell carcinoma; however, they are nonspecific* Central necrosis appears as a cystic area within the node, demonstrating an anechoic, or completely black, echo texture enhanced through transmission ([AJR Am J Roentgenol 2005;184:1691](15855141))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-11",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#radiologyimages236402",
    "clean_content": "Radiology images\n\n*Contributed by Zahra Maleki, M.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealradioMaleki01.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealradioMaleki01.jpg)\n\nUltrasound"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-12",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#prognosticfactors236403",
    "clean_content": "Prognostic factors\n\n* Distant metastasis, although rare, is associated with poor prognosis"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-13",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#casereports236404",
    "clean_content": "Case reports\n\n* 18 year old woman with larynx tumor ([Head Neck 2019;41:E59](30589154))* 52 year old man with metastasis to the pleura ([J Oral Maxillofac Surg 2018;76:2577](30098955))* 61 year old man with solitary dural metastasis ([Head Neck 2014;36:E103](24375789))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-14",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#treatment236405",
    "clean_content": "Treatment\n\n* Resection of primary tumor with or without ipsilateral or bilateral neck dissection* Radiation therapy or systemic therapy in cases with extranodal extension, positive margins or other high risk associated features such as pT3 or pT4 primary, one positive node > 3 cm or multiple positive nodes, nodal metastasis in levels IV or V, perineural invasion, vascular invasion and lymphatic invasion ([National Comprehensive Cancer Network](https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf), [J Am Soc Cytopathol 2016;5:203](31042510))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-15",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#microscopichistologicdescription236406",
    "clean_content": "Microscopic (histologic) description\n\n* Variable squamous differentiation including:\n  + Basaloid features with no squamous differentiation, most common pattern+ Focal keratinization+ Abundant keratinization* Other morphology types:\n    + Nonkeratinizing squamous cell carcinoma with maturation+ Hybrid variant+ Keratinizing SCC+ Cystic / microcystic, ciliated+ Papillary SCC+ Adenosquamous SCC+ Spindle cell carcinoma (sarcomatoid)+ Undifferentiated SCC ([Am J Surg Pathol 2015;39:1591](26457358))* No tumor grade or differentiation status should be reported ([CAP: Human Papillomavirus Testing in Head and Neck Carcinomas [Accessed 24 September 2019]](https://www.cap.org/protocols-and-guidelines/cap-guidelines/current-cap-guidelines/human-papillomavirus-testing-in-head-and-neck-carcinomas))"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-16",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#microscopichistologicimages236407",
    "clean_content": "Microscopic (histologic) images\n\n*Contributed by Zahra Maleki, M.D. and [@AnaPath10](https://twitter.com/AnaPath10) on Twitter*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmicroMaleki01.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmicroMaleki01.jpeg)\n\nInfiltrating tumor\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmicroMaleki02.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmicroMaleki02.jpeg)\n\nBasaloid cells\n\n[![Pulmonary hamartoma](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1001.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1001.jpeg)\n \n[![Pulmonary hamartoma](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1002.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1002.jpeg)\n \n[![Pulmonary hamartoma](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1003.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1003.jpeg)\n \n[![Pulmonary hamartoma](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1004.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealAnaPath1004.jpeg)\n\nHPV positive oropharynx squamous cell carcinoma"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-17",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#cytologydescription236408",
    "clean_content": "Cytology description\n\n* Non / minimally keratinized squamous cell carcinoma, fragments of basaloid cells with high N/C ratio and hyperchromatic nuclei* Fragments of cohesive malignant squamous cells with dense cytoplasm* Variable squamous differentiation, tadpole, snake cells and squamous cells with orangeophilic cytoplasm in Papanicolaou stain and blue in Romanowsky stain, respectively* Individual keratinized cells with marked pleomorphism* Necrosis, cystic degeneration and macrophages, common"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-18",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#cytologyimages236409",
    "clean_content": "Cytology images\n\n*Contributed by Zahra Maleki, M.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki01.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki01.jpeg)\n\nAtypical squamous cells\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki02.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki02.jpeg)\n\nPleomorphism\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki03.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki03.jpeg)\n\nFocal keratinization\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki04.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki04.jpeg)\n\nCohesive fragments\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki05.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki05.jpeg)\n\nBasaloid features\n\n  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki06.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki06.jpeg)\n\nCyst aspiration\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki07.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki07.jpeg)\n\nCell block\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki08.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki08.jpeg)\n\np63\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki09.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealcytoMaleki09.jpeg)\n\np16"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-19",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#positivestains236410",
    "clean_content": "Positive stains\n\n* [p16](https://www.pathologyoutlines.com/topic/stainsp16.html) in ≥ 70% of tumor cells with both nuclear and cytoplasmic staining ([Arch Pathol Lab Med 2018;142:559](29251996)), a surrogate marker* [p40](https://www.pathologyoutlines.com/topic/stainsdeltaNp63.html), [p63](https://www.pathologyoutlines.com/topic/stainsp63.html), [CK5/6](https://www.pathologyoutlines.com/topic/stainsck5and6.html)"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-20",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#molecularcytogeneticsdescription236411",
    "clean_content": "Molecular / cytogenetics description\n\n* Positive for high risk [HPV](https://www.pathologyoutlines.com/topic/stainshpv.html) by hybrid captured II assay, DNA in situ hybridization, RNA in situ hybridization, PCR ([J Am Soc Cytopathol 2016;5:203](31042510))* [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html)-"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-21",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Molecular / cytogenetics images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#molecularcytogeneticsimages236412",
    "clean_content": "Molecular / cytogenetics images\n\n*Contributed by Zahra Maleki, M.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki01.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki01.jpeg)\n\nHigh risk HPV DNA ISH\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki02.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki02.jpeg)\n\nHPV16 DNA ISH\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki03.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki03.jpeg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki04.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavityHPVrelatedoropharyngealmolMaleki04.jpeg)\n\nHPV RNA ISH"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-22",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#samplepathologyreport236413",
    "clean_content": "Sample pathology report\n\n* Lymph node, right level II, ultrasound guided fine needle aspiration:\n  + Metastatic HPV related squamous cell carcinoma (see comment)+ Comment: An immunostain for p16 is positive in 80% of the tumor cells. In situ hybridization for high risk HPV RNA is positive."
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-23",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#differentialdiagnosis236414",
    "clean_content": "Differential diagnosis\n\n* [HPV](https://www.pathologyoutlines.com/topic/stainshpv.html)- [squamous cell carcinoma of oropharynx](https://www.pathologyoutlines.com/topic/oralcavitysccoropharynx.html)\n  + History of heavy alcohol consumption or chewing / smoking tobacco+ Shows higher degree of squamous differentiation in most cases+ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)-, high risk HPV-* Metastatic [squamous cell carcinoma](https://www.pathologyoutlines.com/topic/skintumornonmelanocyticscc.html) of skin\n    + Older patients+ Shows higher degree of squamous differentiation in most cases+ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)-, high risk HPV-* [Lymphoepithelial cyst](https://www.pathologyoutlines.com/topic/salivaryglandsb9lymphoepithelialcyst.html)\n      + Overall less cellularity+ Unilateral and single cyst+ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html) focally positive, HPV-* [Nasopharyngeal carcinoma](https://www.pathologyoutlines.com/topic/nasalnasopharyngealgeneral.html)\n        + Presents as [keratinizing squamous cell carcinoma](https://www.pathologyoutlines.com/topic/nasalscc.html) or [nonkeratinizing squamous cell carcinoma](https://www.pathologyoutlines.com/topic/nasalscc.html) including [basaloid squamous cell carcinoma](https://www.pathologyoutlines.com/topic/oralcavitybasaloidscc.html) and undifferentiated subtype ([El-Naggar: WHO Classification of Head and Neck Tumours, 4th Edition, 2017](https://www.amazon.com/exec/obidos/ASIN/9283224388/pathologyoutl-20))+ Syncytial growth pattern, vesicular nuclei with prominent central nucleoli and reactive lymphocytes in stroma+ Usually positive for [Epstein-Barr virus (EBV)](https://www.pathologyoutlines.com/topic/stainseber1.html) / [Epstein-Barr encoded RNA (EBER)](https://www.pathologyoutlines.com/topic/stainseber1.html)+ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)-, high risk HPV-* Metastatic [squamous cell carcinoma](https://www.pathologyoutlines.com/topic/skintumornonmelanocyticscc.html) of lung\n          + Prior relevant clinical history+ Variable squamous differentiation+ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)-, HPV-* Metastatic HPV related anogenital squamous cell carcinoma including uterine cervix\n            + Prior relevant clinical history+ Cytomorphologic overlap+ Also [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)+ and high risk HPV+* [Adenoid cystic carcinoma](https://www.pathologyoutlines.com/topic/salivaryglandsadenoidcystic.html), solid type\n              + Basaloid tumor cells with high N/C ratio and angulated nuclei+ [CD117](https://www.pathologyoutlines.com/topic/cdmarkerscd117.html) (c-kit)++ [p16](https://www.pathologyoutlines.com/topic/stainsp16.html)-, high risk HPV-* Metastatic [small cell carcinoma](https://www.pathologyoutlines.com/topic/lungtumorsmallcell.html) of the lung\n                + Chest imaging useful to differentiate these two entities+ Same morphology with small cell variant of oropharyngeal carcinoma+ [CD56](https://www.pathologyoutlines.com/topic/cdmarkerscd56.html)+, [chromogranin](https://www.pathologyoutlines.com/topic/stainschromogranin.html)+, [synaptophysin](https://www.pathologyoutlines.com/topic/stainssynaptophysin.html)++ High risk HPV-* Metastatic large cell neuroendocrine carcinoma\n                  + Sheets and three dimensional fragments of cohesive cells with large pleomorphic nuclei and vesicular chromatin+ Mitoses, molding and necrosis common+ Neuroendocrine markers ([chromogranin](https://www.pathologyoutlines.com/topic/stainschromogranin.html), [synaptophysin](https://www.pathologyoutlines.com/topic/stainssynaptophysin.html), [CD56](https://www.pathologyoutlines.com/topic/cdmarkerscd56.html))+, HPV-, [p40](https://www.pathologyoutlines.com/topic/stainsdeltaNp63.html)-"
  },
  {
    "id": "hpv-associated_30199_1750166911.txt-24",
    "source_document": "hpv-associated_30199_1750166911.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityHPVrelatedoropharyngeal.html#additionalreferences236415",
    "clean_content": "Additional references\n\n* [Head Neck Pathol 2017;11:41](28247229)"
  }
]